Roche Venture Fund — Full Portfolio
26 tracked investments · listed companies and verified rows first
Entrada Therapeutics develops intracellular therapeutics using its EEV Platform to target previously inaccessible disease-causing targets within cells, with a pipeline spanning retinal, neuromuscular, and metabolic diseases including Duchenne muscular dystrophy.
BiotechHealthtechMedical DevicesBoston, US
Natarajan Sethuraman(Executive Officer)Peter Kim(Director)Nerissa Kreher(Executive Officer)Kory Wentworth(Executive Officer)Dipal Doshi(Executive Officer, Director)inJohn F. Crowley(Director)
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon
Riley Ennis(Co-Founder and Chief Product Officer)Stuart Lawson(Director)Charles Roberts(Director)Gabriel Otte(Director)
DiogenX is a preclinical-stage biotech company developing biologic therapeutics aimed at restoring insulin-producing beta cells for people with Type 1 diabetes.
BiotechDeep TechDigital HealthHealthtechMarseille, FR
Benjamin Charles(Co-Founder & CEO)Patrick Collombat(Co-Founder & Scientific Advisor)Jean-Pascal Tranié(Co-Founder)
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)
BiotechWatertown, US
Markus Goebel(Director)Christopher Viehbacher(Director)Joseph Zakrzewski(Director)Henry Skinner(Director)Mary Szela(Director)Vikas Goyal(Director)
Board seatAnja Harmeier· per SEC Form D · $20M raise · filed Mar 2018
Aligos is a clinical-stage biotechnology company developing therapeutics for liver and viral diseases, including chronic hepatitis B virus (HBV) infection and MASLD/MASH.
BiotechHealthtechSouth San Francisco, US
Hardean Achneck(Executive Officer)Carole Neuchterlein(Director)Peter Moldt(Director)Sushmita Chanda(Executive Vice President - Preclinical Development)Kathleen Glaub(Director)Brian Dowd(Executive Vice President - Controller)
Bonum Therapeutics is an early-stage biotechnology company.
BiotechSeattle, US
John Mulligan(Executive Officer, Director, Promoter)Neela Patel(Executive Officer)Diane Hollenbaugh(Executive Officer)
BoardSamuel Bjork(Director)Monique Schiersing(Director)John McKearn(Director)
COUR develops targeted therapies for autoimmune diseases using an antigen-specific platform technology designed to restore immune tolerance while preserving normal immune function.
BiotechHealthtechMedical Devices
Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.
BiotechMedical DevicesSan Mateo, US
Jason Coloma(Director)Ann Lee-Karlon(Executive Officer, Director)Samuel Bjork(Director)Alexandra Cantley(Director)Mitchell Mutz(Executive Officer, Director)Seiji Miyahara(Director)
Forcefield Therapeutics develops cardioprotective proteins for the treatment of cardiac disease, with an initial focus on myocardial infarction (heart attack).
BiotechHealthtechMedical Devices
John
BiotechSan Diego, US
Yi Liu(Executive Officer, Director)Lynn Yang(Director)
BoardCarl Gordon(Director)
Mission Therapeutics develops therapeutics targeting deubiquitylating enzymes (DUBs), such as USP30, which regulate ubiquitylation and processes including mitophagy and protein homeostasis.
BiotechHealthtech
NMD Pharma is a clinical-stage biotech company developing first-in-class small-molecule therapies that selectively target skeletal muscle to treat rare neuromuscular diseases and age-related conditions.
BiotechDeep TechHealthtechMedical DevicesAarhus, DK
Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs.
BiotechHealthtechMedical Devices
Ilise Lombardo(Chief Executive Officer)Volker Knappertz(Executive Vice President of Research & Development)Michael Samar(Chief Financial Officer)Rob Lasser(Chief Medical Officer)
BiotechBrisbane, US
Stephen Brady(Director)Matthew Angel(Executive Officer, Director)Nicholas Maestas(Executive Officer)Thomas Woiwode(Director)Geoffrey Nichol(Director)Thomas W. Dubensky(Executive Officer, Director)
Pharmaceutical-technology.com is a B2B media and news website covering pharma, biotech, medical technology, and health tech, part of GlobalData's network of proprietary industry sites.
HealthtechMedia & EntertainmentLondon, GB
Sarepta develops precision genetic medicines for people with rare diseases, with a focus on rare neuromuscular conditions.
BiotechHealthtechCambridge, US
WILLIAM CIAMBRONE(Executive Officer)HANS WIGZELL(Director)CLAUDE NICAISE(Director)DOUGLAS S. INGRAM(Executive Officer, Director)DAVID TYRONNE HOWTON(Executive Officer)MARY ANN GRAY(Director)
Vivet Therapeutics is a company focused on gene and cell therapy development, presenting research at major scientific conferences.
BiotechParis, FR
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.